Andere Sprachen Dr. Lal PathLabs Limited

Aktien

A2ACT9

INE600L01024

LALPATHLAB

Markt geschlossen - NSE India S.E. Andere Börsenplätze 13:58:33 07.06.2024			% 5 Tage	% 1. Jan.
2.798 ^INR	+1,58 %		+6,51 %	+8,56 %

14.05.	DR. LAL PATHLABS LIMITED : Von Nomura zum Kauf angehoben	ZM
10.05.	Transcript : Dr. Lal PathLabs Limited, Q4 2024 Earnings Call, May 10, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6%	13.05.
India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand	10.05.
Dr. Lal PathLabs Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024	10.05.
Dr. Lal PathLabs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	10.05.
Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer, Effective May 9, 2024	26.04.
Dr Lal Pathlabs Names CEO	18.03.
Dr. Lal PathLabs Limited Appoints Shankha Banerjee as Chief Executive Officer, Effective May 21, 2024	17.03.
Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer	03.03.
Dr. Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q3; EPS, Revenue Miss Estimates	02.02.
Dr. Lal PathLabs Seeks M&A	01.02.
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	01.02.
Dr. Lal PathLabs Limited Approves Second Interim Dividend for the Fiscal Year 2023-24	01.02.
Dr. Lal PathLabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01.02.
Dr. Lal Pathlabs Board to Consider Second Interim Dividend for Fiscal 2024	25.01.
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q2; Shares Climb 5%	03.11.
Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	02.11.
Dr. Lal Pathlabs Limited Approves to Declare Final Dividend for the Financial Year Ended March 31, 2023	12.09.23
Dr. Lal PathLabs Limited Announces Change in Directorate	20.08.23
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q1; Revenue Meets Estimates	31.07.23
Dr. Lal PathLabs Seeks Inorganic Opportunity	27.07.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Dr. Lal PathLabs Limited

Aktien

A2ACT9

INE600L01024

LALPATHLAB

Andere Sprachen

Filter